Matrix remodeling-associated protein 5 as a novel biomarker for predicting disease activity and endoscopic response to infliximab in Crohn's disease
The primary objective of treating Crohn's disease (CD) is to achieve and sustain endoscopic remission. However, repeated endoscopic examination leads to decreased patient compliance and procedural risks. Non-invasive biomarkers for endoscopic activity of CD are thus promising in clinical use. T...
Saved in:
| Main Authors: | Daopo Lin, Jiayue Xu, Mengqian Ye, Luyan Fang, Tianhao Xia, Wenyu Tong, Gokuljayanth Jayaseelan Ranichandra, Yifan Bao, Bo Zheng, Yi Jiang, Lianpin Wu, Dingyuan Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-12-01
|
| Series: | Journal of Translational Autoimmunity |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909025000358 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and validation of a nomogram for predicting endoscopic healing in crohn’s disease patients receiving infliximab treatment
by: Lixuan Li, et al.
Published: (2025-07-01) -
Psoas muscle CT radiomics-based machine learning models to predict response to infliximab in patients with Crohn’s disease
by: Zhuoyan Chen, et al.
Published: (2025-12-01) -
Tracing the historical foundations of infliximab in Crohn’s disease treatment: a cited reference analysis
by: Andy Wai Kan Yeung
Published: (2024-11-01) -
Evaluating the predictive effect of vitamin D on clinical outcomes of infliximab-treated Crohn’s disease patients
by: Jiao Zheng, et al.
Published: (2025-06-01) -
Case Report: Facial Malassezia folliculitis following infliximab treatment in Crohn’s disease
by: Liji Chen, et al.
Published: (2025-08-01)